SA.60012(2020/X) We plan to submit application documentation (2 phase) for the planned cut-off date on 6 April 2022 in Horizon Europe — EIC Accelerator OPEN. The competition is organised by the EIC (European Innovation Council) - https://eic.ec.europa.eu/eic-funding-opportunities/eic-accelerator_en. The company will finance its own contribution on its own, and in addition to the grant part, it also intends to use the investment component available under the EIC Accelerator. The competition consists of several phases and requires the preparation of both video material, presentation, a short version of the application and a full version of the application documentation. It may also be necessary to identify clinical centres interested and ready to cooperate. The EIC Accelerator competition assumes the possibility of re-submission of the application, which requires the introduction of corrections/complements. The company, if faced with such an opportunity, will be determined to take advantage of it. We intend to develop the results obtained so far, identify clinical centres that may and are interested in participating in such a study, and prepare a preliminary clinical trial protocol. The project planned to be submitted is a continuation of the B+r work carried out by the Applicant on the device for the removal of clots with acute pulmonary embolism and is intended to extend the registration of the new medical device with peripheral vessels. The European company’s registration of a new device in this indication is almost strategic in the case of an observed growing number of embolisms as one of the consequences of the Covid19 pandemic. It is observed that some of the new episodes have a different mechanism than before and are characterised by a different organisation of thrombosis resistant to anticoagulants. However, before registering in a given indication, a device of this class requires performance and safety tests in accordance with the guidelines of the new Food Safety Regulation. MDR (Medical Device Regulatio)